Physician profile
Brandon Martinez
NPI 1023271947
$226,324.08
in general payments reported to CMS, 2019-2025
35 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79K · 2020: $44K · 2021: $34K · 2022: $49K · 2023: $13K · 2024: $5,971 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $2,045 · Travel and Lodging: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,000.00 |
| Food and Beverage | $2,044.62 |
| Travel and Lodging | $1,051.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $223,365.60 | 2019-2024 | Sir-Spheres Microspheres |
| Inari Medical, INC. | $737.69 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Terumo Medical Corporation | $432.95 | 2019-2025 | Hydropearl, Azur Cx Detachable, Angio-Seal |
| Abbott Laboratories | $255.17 | 2020-2025 | Armada, Perclose Proglide |
| Trisalus Life Sciences, INC. | $147.60 | 2021 | |
| Bard Peripheral Vascular, INC. | $143.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $128.35 | 2025 | |
| Balt USA, LLC | $122.85 | 2021 | |
| Janssen Biotech, INC. | $116.21 | 2025 | Erleada |
| Urogen Pharma, INC. | $81.75 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.67 | 2019-2025 | |
| Nevro Corp. | $64.47 | 2020 | |
| Progenics Pharmaceuticals, INC. | $57.01 | 2025 | |
| Accord Healthcare, INC. | $48.98 | 2025 | |
| Cook Medical LLC | $48.76 | 2025 | Tornado |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $39.96 | 2025 | Lynparza |
| Sumitomo Pharma America, INC. | $39.40 | 2025 | Orgovyx |
| Immunitybio, INC. | $36.13 | 2025 | |
| Endo USA, INC. | $33.77 | 2025 | Aveed, Xiaflex |
| Dendreon Pharmaceuticals LLC | $32.80 | 2025 | Provenge |
| Dentsply Ih Ab | $32.77 | 2025 | Lofric |
| Cardiovascular Systems INC. | $29.11 | 2020-2021 | |
| Laborie Medical Technologies Corp. | $28.47 | 2025 | |
| Philips North America LLC | $26.60 | 2021 | |
| Organon LLC | $25.97 | 2025 | |
| Stryker Corporation | $22.99 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Argon Medical Devices, INC. | $22.91 | 2025 | Clot Management |
| Medtronic, INC. | $19.98 | 2025 | Altaviva |
| Myriad Genetic Laboratories, INC. | $17.80 | 2025 | Prolaris |
| Asahi Intecc USA, INC. | $16.88 | 2025 | Asahi Coronary Wires |
| W. L. Gore & Associates, INC. | $15.67 | 2019 | |
| Z-Medica, LLC | $14.65 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.13 | 2024 | Jardiance |
| Angiodynamics, INC. | $14.02 | 2022 | |
| Penumbra, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.